152 related articles for article (PubMed ID: 1723260)
1. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
[TBL] [Abstract][Full Text] [Related]
2. Vimentin expression in benign and malignant lesions in the human mammary gland.
Wada T; Yasutomi M; Hashmura K; Kunikata M; Tanaka T; Mori M
Anticancer Res; 1992; 12(6B):1973-82. PubMed ID: 1284196
[TBL] [Abstract][Full Text] [Related]
3. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
[TBL] [Abstract][Full Text] [Related]
4. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
Dalal P; Shousha S
Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941
[TBL] [Abstract][Full Text] [Related]
5. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
Gottlieb C; Raju U; Greenwald KA
Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
[TBL] [Abstract][Full Text] [Related]
6. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity and co-expression of intermediate filament proteins in adenoid cystic carcinoma of salivary glands.
Chomette G; Auriol M; Vaillant JM; Kasai T; Okada Y; Mori M
Pathol Biol (Paris); 1991 Feb; 39(2):110-6. PubMed ID: 1708120
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.
Böcker W; Bier B; Freytag G; Brömmelkamp B; Jarasch ED; Edel G; Dockhorn-Dworniczak B; Schmid KW
Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):323-30. PubMed ID: 1384227
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
Bässler R; Katzer B
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
13. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
14. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
15. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors].
Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Liubimov AV
Arkh Patol; 1990; 52(9):12-8. PubMed ID: 1702969
[TBL] [Abstract][Full Text] [Related]
18. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast.
Wetzels RH; Holland R; van Haelst UJ; Lane EB; Leigh IM; Ramaekers FC
Am J Pathol; 1989 Mar; 134(3):571-9. PubMed ID: 2466404
[TBL] [Abstract][Full Text] [Related]
19. Expression of luminal and basal cytokeratins in human breast carcinoma.
Abd El-Rehim DM; Pinder SE; Paish CE; Bell J; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
J Pathol; 2004 Jun; 203(2):661-71. PubMed ID: 15141381
[TBL] [Abstract][Full Text] [Related]
20. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.
Gusterson BA; Warburton MJ; Mitchell D; Ellison M; Neville AM; Rudland PS
Cancer Res; 1982 Nov; 42(11):4763-70. PubMed ID: 6290045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
